Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, Connecticut 06269, United States.
Department of Chemical & Biomolecular Engineering, University of Connecticut, 191 Auditorium Road, Unit 3222, Storrs, Connecticut 06269, United States.
Mol Pharm. 2024 Nov 4;21(11):5510-5528. doi: 10.1021/acs.molpharmaceut.4c00751. Epub 2024 Sep 27.
The particle drifting effect, where nanosized colloidal drug particles overcome the diffusional resistance of the aqueous boundary layer adjacent to the intestinal wall and increase drug absorption rates, is drawing increasing attention in pharmaceutical research. However, mechanistic understanding and accurate prediction of the particle drifting effect remain lacking. In this study, we systematically evaluated the extent of the particle drifting effect affected by drug and colloidal properties, including the size, number, and type of the moving species using biphasic diffusion experiments combined with computational fluid dynamics simulations and mass transport analyses. The results showed that the particle drifting effect is a sequential reaction of particle dissolution/dissociation in the diffusional boundary layer, followed by absorption of the free drug. Therefore, factors affecting the rate-limiting step, which can be either process or both under different circumstances, alter the particle drifting effect. Experimental results also agree with the theory that the particle dissolution rate is dependent on particle size, concentration, and drug solubility. In addition, rapid bile micelle dissociation and bile salt absorption facilitated drug absorption by the particle drifting effect. Our findings explain the highly dynamic nature of the particle drifting effect and will contribute to rational formulation development and better bioavailability prediction for formulations containing colloidal particles.
纳米级胶体药物粒子克服与肠壁相邻的水相边界层的扩散阻力并增加药物吸收率的粒子漂移效应在药物研究中受到越来越多的关注。然而,对于粒子漂移效应的机制理解和准确预测仍然缺乏。在这项研究中,我们使用两相扩散实验结合计算流体动力学模拟和质量传输分析,系统地评估了受药物和胶体性质影响的粒子漂移效应的程度,包括运动物种的大小、数量和类型。结果表明,粒子漂移效应是扩散边界层中粒子溶解/解离的连续反应,随后是游离药物的吸收。因此,影响限速步骤的因素(在不同情况下可能是过程或两者)改变了粒子漂移效应。实验结果也符合理论,即粒子溶解速率取决于粒子大小、浓度和药物溶解度。此外,快速胆汁胶束解离和胆汁盐吸收通过粒子漂移效应促进药物吸收。我们的研究结果解释了粒子漂移效应的高度动态性质,并将有助于合理的制剂开发和更好地预测含有胶体粒子的制剂的生物利用度。